235 related articles for article (PubMed ID: 33731144)
41. Identification of Flap endonuclease 1 as a potential core gene in hepatocellular carcinoma by integrated bioinformatics analysis.
Li C; Qin F; Hong H; Tang H; Jiang X; Yang S; Mei Z; Zhou D
PeerJ; 2019; 7():e7619. PubMed ID: 31534853
[TBL] [Abstract][Full Text] [Related]
42. DNA primase subunit 1 deteriorated progression of hepatocellular carcinoma by activating AKT/mTOR signaling and UBE2C-mediated P53 ubiquitination.
Zhu M; Wu M; Bian S; Song Q; Xiao M; Huang H; You L; Zhang J; Zhang J; Cheng C; Ni W; Zheng W
Cell Biosci; 2021 Feb; 11(1):42. PubMed ID: 33622397
[TBL] [Abstract][Full Text] [Related]
43. Identifying biomarkers of papillary renal cell carcinoma associated with pathological stage by weighted gene co-expression network analysis.
He Z; Sun M; Ke Y; Lin R; Xiao Y; Zhou S; Zhao H; Wang Y; Zhou F; Zhou Y
Oncotarget; 2017 Apr; 8(17):27904-27914. PubMed ID: 28427189
[TBL] [Abstract][Full Text] [Related]
44. Identification and Validation of Hub Genes Associated With Hepatocellular Carcinoma
Wang S; Song Z; Tan B; Zhang J; Zhang J; Liu S
Front Oncol; 2021; 11():614531. PubMed ID: 34277395
[TBL] [Abstract][Full Text] [Related]
45. Identification of Biomarkers Associated With Pathological Stage and Prognosis of Clear Cell Renal Cell Carcinoma by Co-expression Network Analysis.
Chen L; Yuan L; Qian K; Qian G; Zhu Y; Wu CL; Dan HC; Xiao Y; Wang X
Front Physiol; 2018; 9():399. PubMed ID: 29720944
[TBL] [Abstract][Full Text] [Related]
46. SFPQ promotes the proliferation, migration and invasion of hepatocellular carcinoma cells and is associated with poor prognosis.
Lin Y; Zhong W; Lin Q; Ye Y; Li S; Chen H; Liu H; Xu L; Zhuang W; Chen S; Lin Y; Wang Q
Am J Cancer Res; 2023; 13(6):2269-2284. PubMed ID: 37424798
[TBL] [Abstract][Full Text] [Related]
47. Three novel hub genes and their clinical significance in clear cell renal cell carcinoma.
Xiao H; Chen P; Zeng G; Xu D; Wang X; Zhang X
J Cancer; 2019; 10(27):6779-6791. PubMed ID: 31839812
[No Abstract] [Full Text] [Related]
48. Comprehensive investigation of key biomarkers and pathways in hepatitis B virus-related hepatocellular carcinoma.
Liao X; Yu T; Yang C; Huang K; Wang X; Han C; Huang R; Liu X; Yu L; Zhu G; Su H; Qin W; Deng J; Zeng X; Han B; Han Q; Liu Z; Zhou X; Liu J; Gong Y; Liu Z; Huang J; Lu L; Ye X; Peng T
J Cancer; 2019; 10(23):5689-5704. PubMed ID: 31737106
[No Abstract] [Full Text] [Related]
49. Integrative module analysis of HCC gene expression landscapes.
Li H; Wei N; Ma Y; Wang X; Zhang Z; Zheng S; Yu X; Liu S; He L
Exp Ther Med; 2020 Mar; 19(3):1779-1788. PubMed ID: 32104233
[TBL] [Abstract][Full Text] [Related]
50. Identification of CXCL13 as a potential biomarker in clear cell renal cell carcinoma via comprehensive bioinformatics analysis.
Xu T; Ruan H; Song Z; Cao Q; Wang K; Bao L; Liu D; Tong J; Yang H; Chen K; Zhang X
Biomed Pharmacother; 2019 Oct; 118():109264. PubMed ID: 31390578
[TBL] [Abstract][Full Text] [Related]
51. Identification of Key Pathways and Genes in the Dynamic Progression of HCC Based on WGCNA.
Yin L; Cai Z; Zhu B; Xu C
Genes (Basel); 2018 Feb; 9(2):. PubMed ID: 29443924
[TBL] [Abstract][Full Text] [Related]
52. Identification of key genes for predicting colorectal cancer prognosis by integrated bioinformatics analysis.
Dai GP; Wang LP; Wen YQ; Ren XQ; Zuo SG
Oncol Lett; 2020 Jan; 19(1):388-398. PubMed ID: 31897151
[TBL] [Abstract][Full Text] [Related]
53. Novel Potential Biomarkers Associated With Epithelial to Mesenchymal Transition and Bladder Cancer Prognosis Identified by Integrated Bioinformatic Analysis.
Wang C; Yang Y; Yin L; Wei N; Hong T; Sun Z; Yao J; Li Z; Liu T
Front Oncol; 2020; 10():931. PubMed ID: 32695668
[TBL] [Abstract][Full Text] [Related]
54. Identification of the Potential Prognosis Biomarkers in Hepatocellular Carcinoma: An Analysis Based on WGCNA and PPI.
Huang J; Zhan Y; Jiang L; Gao Y; Zhao B; Zhang Y; Zhang W; Zheng J; Yu J
Int J Gen Med; 2021; 14():9555-9565. PubMed ID: 34916837
[TBL] [Abstract][Full Text] [Related]
55. Co-expression network analysis identified six hub genes in association with progression and prognosis in human clear cell renal cell carcinoma (ccRCC).
Yuan L; Chen L; Qian K; Qian G; Wu CL; Wang X; Xiao Y
Genom Data; 2017 Dec; 14():132-140. PubMed ID: 29159069
[TBL] [Abstract][Full Text] [Related]
56. Co-expression Network Analysis Identifies Four Hub Genes Associated With Prognosis in Soft Tissue Sarcoma.
Zhu Z; Jin Z; Deng Y; Wei L; Yuan X; Zhang M; Sun D
Front Genet; 2019; 10():37. PubMed ID: 30778371
[No Abstract] [Full Text] [Related]
57. Identifying hub genes and dysregulated pathways in hepatocellular carcinoma.
Jin B; Wang W; Du G; Huang GZ; Han LT; Tang ZY; Fan DG; Li J; Zhang SZ
Eur Rev Med Pharmacol Sci; 2015 Feb; 19(4):592-601. PubMed ID: 25753876
[TBL] [Abstract][Full Text] [Related]
58. A transcriptional co-expression network-based approach to identify prognostic biomarkers in gastric carcinoma.
Liu D; Zhou B; Liu R
PeerJ; 2020; 8():e8504. PubMed ID: 32095347
[TBL] [Abstract][Full Text] [Related]
59. SPINK5 is a Prognostic Biomarker Associated With the Progression and Prognosis of Laryngeal Squamous Cell Carcinoma Identified by Weighted Gene Co-Expression Network Analysis.
Liu J; Zhao J; Xu J; Sun Q; Qin X; Chen G; Gao T; Bai G; Guo Z
Evol Bioinform Online; 2022; 18():11769343221077118. PubMed ID: 35140453
[TBL] [Abstract][Full Text] [Related]
60. Identification of Potential Gene Network Associated with HCV-Related Hepatocellular Carcinoma Using Microarray Analysis.
Cheng Y; Ping J; Chen J
Pathol Oncol Res; 2018 Jul; 24(3):507-514. PubMed ID: 28669080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
